Fig. 7From: The use of long-acting Aripiprazole in a multi-center, prospective, uncontrolled, open-label, cohort study in Germany: a report on global assessment of functioning and the WHO wellbeing indexAssessment of effectiveness and tolerability of AOM treatment by treating physicians and patientsBack to article page